loading...| Preferred Name |
hetastarch |
|
| Synonyms |
Hespan |
|
| Definitions |
A synthetic, nonionic hydroxyethyl derivative of starch used as a plasma expander when prepared in an isotonic solution. Upon intravenous administration, hydroxyethyl starch colloid increases blood volume and thus improves circulation. This agent is almost exclusively excreted by the kidneys and is potentially nephrotoxic. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C559" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C559" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000735726 |
|
| altLabel |
Hespan HES Voluven venofundin hydroxyethyl starch Volulyte Hextend |
|
| cui |
C3642349 C3642348 C0699405 C1170317 C1451362 C0020352 |
|
| DATE FIRST PUBLISHED |
2012-06-19 |
|
| Date last modified |
2012-07-31 |
|
| definition |
A synthetic, nonionic hydroxyethyl derivative of starch used as a plasma expander when prepared in an isotonic solution. Upon intravenous administration, hydroxyethyl starch colloid increases blood volume and thus improves circulation. This agent is almost exclusively excreted by the kidneys and is potentially nephrotoxic. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C559" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C559" NCI Thesaurus) |
|
| LT |
TRD |
|
| NCI ID |
C559 |
|
| notation |
CDR0000735726 |
|
| ORIG STY |
Drug/agent |
|
| prefLabel |
hetastarch |
|
| tui |
T109 T121 |